Type I Diabetes Mellitus can be defined as a chronic illness characterized by the inability of the body to produce insulin due to the autoimmune disorder in which the beta cells of the pancreas are destroyed by the body’s own immune system. The symptoms of type I diabetes include excessive urination known as polyuria; excessive hunger or polyphagia; excessive thirst or polydipsia; weight loss, dry mouth, blurred vision, and fatigue. The diagnosis of type I diabetes includes identification of the presence of diabetic ketoacidosis. Symptoms of diabetic ketoacidosis include drowsiness, frequent urination, increased thirst, dry skin, nausea, and abdominal pain. The exact cause of type I diabetes mellitus is not clear; however, it is known to be caused by genetic factors, exposure to an antigen or diabetogenic trigger. This form of diabetes is known to be very common among children and young adults.

Type I diabetes mellitus treatment market is anticipated to grow significantly owing to the availability of insulin as the major mode of treatment, which is likely to contribute to the growth of the market. The rising prevalence of the disease contributing to the increasing patient pool aids in the type I diabetes mellitus treatment market growth. For instance, over 1.25 million American children and adults are expected to suffer from type I diabetes in 2017. According to the WHO, prevalence of type I diabetes mellitus is anticipated to be significantly higher in Sardinia, New Zealand, Sweden, Finland, Norway, the U.K., Portugal, and Canada. In addition, growing focus on research and development, the growing pipeline of exogenous insulin products, and government funding for research on treatment modes for type I diabetes mellitus aid in the growth of the market. However, increasing patent expiries, and rising usage of biologics leading to price competition among market players, might hamper the future growth of the type I diabetes mellitus treatment market. 

The global type I diabetes mellitus treatment market can be segmented on the basis of insulin analogs, distribution channel, and geography. On the basis of insulin analogs, the type I diabetes mellitus treatment market can be segmented into long acting insulin analog, premix analogs, rapid acting insulin analogs, and others. The other forms of treatment for type I diabetes include pancreatic transplantation, islets of Langerhans transplantation, and dietary supplements. On the basis of distribution channel, the type I diabetes mellitus treatment market can be segmented into hospital pharmacies, retail pharmacies, specialty pharmacies, and others. 

Geographically, the global type I diabetes mellitus treatment market can be segmented into five regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for the highest share of the global type I diabetes mellitus treatment market in terms of revenue in 2016 and the trend is anticipated to continue during the forecast period. Strong growth in the region can be attributed to increase in well-established health care infrastructure and increasing prevalence of type I diabetes among the people. Europe is expected to be the second leading market for type I diabetes mellitus treatment. However, the sluggish economy in the region is likely to negatively impact the growth of the type I diabetes mellitus treatment market. The type I diabetes mellitus treatment market in Asia Pacific is anticipated to record high CAGR owing to factors such as the growing government focus on enhancing health care facilities and increasing patient population.

Leading players operating in the global Type I diabetes mellitus treatment market are Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Merck & Co., Inc., Novartis International AG, AstraZeneca plc, Biocon Limited, ADOCIA, Bioton, and Wockhardt Ltd., among others. However, the market is anticipated to be dominated by three leading players comprising Sanofi, Eli Lilly, and Novo Nordisk. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.